OncoTartis nets $6 mln
Buffalo, New York-based OncoTartis, a developer of anti-cancer drugs, has secured $6 million in funding. The investors included Norma Investments representing Roman Abramovich and Pharmstandard International S.A.
11 December 2017•1 min read
